← All trials
NCT04724473
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 10, 2019
- Primary completion
- Nov 21, 2020
- Completion date
- Nov 21, 2020
- First posted
- Jan 26, 2021
- Last posted
- Apr 1, 2021
- Enrollment
- 1030
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Taro PharmaceuticalsLead sponsor
- Catawba Clinical ResearchStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.